Although target cell cytolysis has been widely employed to describe effector function of cells, cytolysis assays as commonly employed do not generate quantitative data. In this report we describe the development and application of a statistically supported flow cytometry-based assay to quantify cell-mediated cytolysis. The assay depends on the use of the fluorescent dye CFSE to distinguish target from effector cells, the DNA intercalating dye 7AAD to distinguish dead from live cell events, and on the establishment of a cytolysis curve that allows for the derivation of statistically robust data. We demonstrate that the cytolysis curve is well described by a four parameter logistic regression model provided that (i) the range of effector to target (E:T) ratios studied allows for full description of the logistic curve, and (ii) an adequate number of data points are collected to estimate the model parameters. We show that the assay is highly reproducible and accurate, and comparable in sensitivity with the standard 51 Cr assay. We report on the potential for this assay to generate quantitative data on the cytolytic activity of both CD8 T and NK cells; describe a relationship between the efficiency of effector cell degranulation and target cell cytolysis throughout a range of E:T ratios, and demonstrate the potential to multiplex with other platforms to obtain broader datasets for the effector phenotype of cells. Appropriate use of this assay will enhance the ability to derive quantitative and integrated correlative datasets from basic, translational, and clinical studies. ' The most commonly employed assay to measure target cell lysis is the 51 Cr release assay (1). Although the 51 Cr release assay has enjoyed wide use and has provided useful data in a large number of clinical and basic research studies, the assay suffers from certain intrinsic limitations. Specifically, (i) the use of a radioactive element ( 51 Cr) with attendant issues of licensing, isotope half-life, storage, disposal, and compliance, (ii) the requirement for metabolic labeling, since metabolically slow cells can label very poorly, and cells at different metabolic states may be differentially resistant to lysis, and (iii) despite the fact that cytolysis is reported in the context of effector:target cell ratios (E:T), the read-out from 51 Cr-based assays is not based on a per-cell measurement but rather on bulk release of radioactivity into the culture medium.